PETラジオトレーサーの世界市場2022-2031：産業分析、規模、シェア、成長、動向、予測

• 英文タイトル：PET Radiotracer Market (Product: F-18 [FDG18], Ga-68 [FAPI], and Others; and Application: Cancer, Heart Disease, Gastrointestinal, Endocrine, Neurological Disorders, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

• レポートコード：MRC2211A082 • 出版社/出版日：Transparency Market Research / 2022年9月 • レポート形態：英文、PDF、152ページ • 納品方法：Eメール • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥857,660 (USD5,795)	▷ お問い合わせ
Multi User	￥1,301,660 (USD8,795)	▷ お問い合わせ
Corporate License	￥1,745,660 (USD11,795)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

トレンスペアレンシーマーケットリサーチ社の当調査レポートでは、世界のPETラジオトレーサー市場を総合的に調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品別（F - 18[FDG18]、Ga - 68[FAPI]、その他）分析、用途別（癌、心臓病、胃腸疾患、内分泌疾患、その他）分析、エンドユーザー別（病院、診断センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの内容を掲載しています。なお、当書には、ABX advanced biochemical compounds GmbH (Cambridge Isotope Laboratories, Inc.)、Blue Earth Diagnostics、Cardinal Health、Eli Lilly and Company、GE Healthcare、IBA Radiopharma Solutions、Jubilant Pharma Limited、Lantheus Holdings, Inc.などの企業情報が含まれています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界のPETラジオトレーサー市場規模：製品別 - F - 18[FDG18]の市場規模 - Ga - 68[FAPI]の市場規模 - その他製品の市場規模 ・世界のPETラジオトレーサー市場規模：用途別 - 癌における市場規模 - 心臓病における市場規模 - 胃腸疾患における市場規模 - 内分泌疾患における市場規模 - その他用途における市場規模 ・世界のPETラジオトレーサー市場規模：エンドユーザー別 - 病院における市場規模 - 診断センターにおける市場規模 - その他エンドユーザーにおける市場規模 ・世界のPETラジオトレーサー市場規模：地域別 - 北米のPETラジオトレーサー市場規模 - ヨーロッパのPETラジオトレーサー市場規模 - アジア太平洋のPETラジオトレーサー市場規模 - 中南米のPETラジオトレーサー市場規模 - 中東・アフリカのPETラジオトレーサー市場規模 ・競争状況

PET Radiotracer Market – Scope of Report

TMR’s report on the global PET radiotracer market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global PET radiotracer market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global PET radiotracer market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the PET radiotracer market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global PET radiotracer market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global PET radiotracer market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global PET radiotracer market.

The report delves into the competitive landscape of the global PET radiotracer market. Key players operating in the global PET radiotracer market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global PET radiotracer market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market PET radiotracer.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

レポート目次

---

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global PET Radiotracer Market
4. Market Overview
4.1. Introduction
4.1.1. Radiotracer Type Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global PET Radiotracer Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Regulatory Scenario by Region/globally
5.2. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.3. Technological Advancements
5.4. COVID 19 Impact Analysis
6. Global PET Radiotracer Market Analysis and Forecast, by Radiotracer Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Radiotracer Type, 2017–2031
6.3.1. F-18 (FDG18)
6.3.2. Ga-68 (FAPI)
6.3.3. Others
6.4. Market Attractiveness Analysis, by Radiotracer Type
7. Global PET Radiotracer Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Cancer
7.3.2. Heart Disease
7.3.3. Gastrointestinal
7.3.4. Endocrine
7.3.5. Neurological Disorders
7.3.6. Others
7.4. Market Attractiveness Analysis, by Application
8. Global PET Radiotracer Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Diagnostic Centers
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global PET Radiotracer Market Analysis and Forecast, by Country/Region
9.1. Key Findings
9.2. Market Value Forecast, by Country/Region
9.2.1. U.S.
9.2.2. Europe
9.2.3. Rest of the World
9.3. Market Attractiveness Analysis, by Country/Region
10. U.S. PET Radiotracer Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Radiotracer Type, 2017–2031
10.2.1. F-18 (FDG18)
10.2.2. Ga-68 (FAPI)
10.2.3. Others
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Cancer
10.3.2. Heart Disease
10.3.3. Gastrointestinal
10.3.4. Endocrine
10.3.5. Neurological Disorders
10.3.6. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Diagnostic Centers
10.4.3. Others
10.5. Market Attractiveness Analysis
10.5.1. By Radiotracer Type
10.5.2. By Application
10.5.3. By End-user
11. Europe PET Radiotracer Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Radiotracer Type, 2017–2031
11.2.1. F-18 (FDG18)
11.2.2. Ga-68 (FAPI)
11.2.3. Others
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Cancer
11.3.2. Heart Disease
11.3.3. Gastrointestinal
11.3.4. Endocrine
11.3.5. Neurological Disorders
11.3.6. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Diagnostic Centers
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Radiotracer Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Rest of the World PET Radiotracer Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Radiotracer Type, 2017–2031
12.2.1. F-18 (FDG18)
12.2.2. Ga-68 (FAPI)
12.2.3. Others
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Cancer
12.3.2. Heart Disease
12.3.3. Gastrointestinal
12.3.4. Endocrine
12.3.5. Neurological Disorders
12.3.6. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Diagnostic Centers
12.4.3. Others
12.5. Market Attractiveness Analysis
12.5.1. By Radiotracer Type
12.5.2. By Application
12.5.3. By End-user
13. Competition Landscape
13.1. Market Player – Competition Matrix (By Tier and Size of companies)
13.2. Market Share Analysis By Company (2021)
13.3. Company Profiles
13.3.1. ABX advanced biochemical compounds GmbH
13.3.1.1. Company Overview
13.3.1.2. Strategic Overview
13.3.1.3. SWOT Analysis
13.3.2. Blue Earth Diagnostics
13.3.2.1. Company Overview
13.3.2.2. Financial Overview
13.3.2.3. Strategic Overview
13.3.2.4. SWOT Analysis
13.3.3. Cardinal Health
13.3.3.1. Company Overview
13.3.3.2. Financial Overview
13.3.3.3. Strategic Overview
13.3.3.4. SWOT Analysis
13.3.4. Eli Lilly and Company
13.3.4.1. Company Overview
13.3.4.2. Financial Overview
13.3.4.3. Strategic Overview
13.3.4.4. SWOT Analysis
13.3.5. GE Healthcare
13.3.5.1. Company Overview
13.3.5.2. Financial Overview
13.3.5.3. Strategic Overview
13.3.5.4. SWOT Analysis
13.3.6. IBA Radiopharma Solutions
13.3.6.1. Company Overview
13.3.6.2. Financial Overview
13.3.6.3. Strategic Overview
13.3.6.4. SWOT Analysis
13.3.7. Jubilant Pharma Limited
13.3.7.1. Company Overview
13.3.7.2. Financial Overview
13.3.7.3. Strategic Overview
13.3.7.4. SWOT Analysis
13.3.8. Lantheus Holdings, Inc.
13.3.8.1. Company Overview
13.3.8.2. Financial Overview
13.3.8.3. Strategic Overview
13.3.8.4. SWOT Analysis
13.3.9. Siemens Healthineers AG
13.3.9.1. Company Overview
13.3.9.2. Financial Overview
13.3.9.3. Strategic Overview
13.3.9.4. SWOT Analysis
13.3.10. Yantai Dongcheng Pharmaceutical Group Co., Ltd.
13.3.10.1. Company Overview
13.3.10.2. Financial Overview
13.3.10.3. Strategic Overview
13.3.10.4. SWOT Analysis

List of Tables

Table 01: Global PET Radiotracer Market Value (US$ Mn) Forecast, by Radiotracer Type, 2017–2031

Table 02: Global PET Radiotracer Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 03: Global PET Radiotracer Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global PET Radiotracer Market Value (US$ Mn) Forecast, by Country/Region, 2017–2031

Table 05: U.S. PET Radiotracer Market Value (US$ Mn) Forecast, by Radiotracer Type, 2017–2031

Table 06: U.S. PET Radiotracer Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 07: U.S. PET Radiotracer Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 08: Europe PET Radiotracer Market Value (US$ Mn) Forecast, by Radiotracer Type, 2017–2031

Table 09: Europe PET Radiotracer Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 10: Europe PET Radiotracer Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 11: Europe PET Radiotracer Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 12: Rest of the World PET Radiotracer Market Value (US$ Mn) Forecast, by Radiotracer Type, 2017–2031

Table 13: Rest of the World PET Radiotracer Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 14: Rest of the World PET Radiotracer Market Value (US$ Mn) Forecast, by End-user, 2017–2031

---